Agitation and aggression in dementia — it's the disease, not the person

This article is for educational purposes only and does not constitute medical, legal, or financial advice. Every family situation is different, and you should consult with appropriate professionals about your specific circumstances.

Your parent's doctor mentions that there are clinical trials happening for their condition. Maybe there's a trial for a new medication that might slow Alzheimer's progression. Maybe there's a trial for a treatment approach that hasn't been tried yet. The doctor frames it as an opportunity. Contributing to research, helping scientists understand more, maybe getting access to something that could help your parent. You feel a pull toward it immediately. This is something. This is a way to fight back against the diagnosis, to do something active instead of just watching decline happen.

But there's also hesitation. Clinical trials are experimental. They're research, not treatment. Your parent might get the real medication or they might get a placebo. They might experience side effects. They might spend time traveling to appointments and participating in protocols that don't actually help them. They might be harmed. You're not a scientist and you don't know how to evaluate whether this trial is well-designed or risky or worth your parent's time and vulnerability.

The emotional pull toward clinical trials is strong because it offers something that very few other options offer: hope that something new might help. But whether your parent should participate depends on understanding what trials actually are, what the real chances are, and what your parent actually wants.

What Clinical Trials Are

Clinical trials are research studies. They're how new medications and treatments get tested in humans to see if they work and if they're safe. Before a medication can be approved by the FDA and prescribed by doctors, it has to go through a long process of testing, and most of that testing involves clinical trials with human participants.

The process typically works like this: a new medication or treatment is discovered or developed. It gets tested in laboratories and in animals first. If it looks promising, researchers want to test it in people. They design a clinical trial to answer specific research questions about whether the treatment works and whether it's safe. They find people who are willing to participate. They randomly assign participants to get either the new treatment or a control condition, often a placebo. They follow people over time, measuring outcomes, watching for side effects. They analyze the data to see if the treatment did what they hoped it would do.

For your parent, participating in a trial means being part of this research process. It means being willing to take a medication or receive a treatment that hasn't been fully proven to work yet. It means giving informed consent, which means understanding what you're consenting to. It means following the trial protocol—the specific rules about medication dosing, visits, tests, and monitoring. It means being monitored carefully for safety. It means being willing to either get the treatment or get a placebo.

The trials that are happening right now for neurodegenerative diseases are often studying medications that show promise in laboratory studies or in earlier stages of testing. They might be studying biological agents that target underlying disease mechanisms. They might be studying rehabilitation or training approaches. They might be studying combinations of existing treatments in new ways. The researchers genuinely don't know whether these approaches will work or what side effects they might cause. That's why they're doing the trial.

Your parent's participation matters for science. Every person in a trial generates data that researchers use to understand whether a treatment works. If enough people participate in trials and the results show that something works, then eventually that something can be approved and prescribed to lots of people. So participating in a trial is a way of contributing to medical knowledge and potentially helping people in the future, including people with your parent's condition.

This is important and real, and it's also not the same as helping your parent. The trial might help your parent, or it might not. That depends on whether the treatment being tested actually works, whether your parent is the kind of person it works for, and luck.

The Reality

Here's what you need to understand about clinical trials in conditions like Alzheimer's disease and other neurodegenerative diseases: most trials don't produce breakthroughs. Most medications being tested don't work, or work only slightly, or work in a small subset of people. The ones that do show some benefit show modest benefit. You're not signing your parent up for a cure. You're signing them up to potentially get a medication that might slow decline a little bit over a few years.

There are a few newer medications for early Alzheimer's disease that are approved now based on clinical trial data showing they slow cognitive decline by a modest amount—we're talking a few months of delay in progression. So instead of someone with mild cognitive impairment transitioning to mild dementia in three years, they might transition in three years and two months. That's the level of benefit being seen. It's not nothing. But it's not the game changer that the emotional pull toward trials wants it to be.

In trials for later-stage disease or for other neurodegenerative diseases, the results are even more modest or nonexistent. Many trials don't show any benefit at all. They're negative trials. The thing being tested didn't work. Your parent spent months or years in the trial, following protocols, coming to appointments, getting blood drawn, potentially experiencing side effects, and at the end of the trial the data shows that the medication didn't help. That's valuable for science. The researchers learn something from negative trials. But it's not helpful for your parent.

Some trials are actually learning trials, studying whether your parent is the kind of person the treatment works for. These are called precision medicine trials, or stratified trials. They're testing whether a treatment works in people with certain genetic markers or biomarker profiles. These trials have more promise because they're trying to match treatments to the people most likely to benefit. But they're also more complex and they're not testing treatments that have been proved to work yet. They're investigating whether specific treatments might work for specific subsets of people.

Your parent might get the real medication or they might get a placebo. If the trial is double-blind, the researchers don't know who gets what and your parent doesn't know who gets what. This is scientifically rigorous but it means your parent is taking a pill for months without knowing if it's the real thing or sugar. Some trials are open-label, meaning everyone knows they're getting the real medication. These are less scientifically rigorous because of the placebo effect and other psychological factors, but they're more ethically straightforward. Your parent knows they're getting the real thing.

The length of trials varies. Some last a few months. Others last a year or more. During this time your parent is expected to come to study visits regularly, undergo testing, maintain a treatment protocol. The burden can be significant, especially if your parent is older and has transportation challenges or lives far from the research center.

Side effects are a possibility. Most of the medications being tested in dementia trials are being tested because they target some aspect of Alzheimer's disease biology. This might be amyloid, or tau, or neuroinflammation, or some other mechanism. Targeting these things can cause side effects. Amyloid-targeting monoclonal antibodies, for example, can cause amyloid-related imaging abnormalities—ARIA,which are changes in the brain that can be dangerous. Some people get brain microhemorrhages. Some people develop amyloid-related brain edema. These are handled by careful monitoring with MRI scans, but they're real risks.

Your parent might participate in a trial and experience side effects without getting any benefit. This is a real possibility and it happens.

What to Consider

If your parent's doctor thinks they would be a good candidate for a trial and you're considering it, there are specific things to think through.

First, eligibility. Not every person with a condition can participate in every trial. Trials have inclusion and exclusion criteria. Your parent might have a condition that meets the diagnosis for the trial but not meet other criteria. They might be too old or too young. They might have other medical conditions that would make the trial dangerous. They might be taking medications that interfere with the trial medication. The trial team will determine if your parent is eligible, and if they're not, that's final. But you should understand what the criteria are so you're not surprised.

Time commitment matters. How often does your parent need to come in for study visits? How long are the visits? Some trials require monthly visits, some require every-two-weeks visits, some require weekly visits in the beginning and then less frequent later. Some visits might be a few hours long. Some might be longer. Is this realistic for your parent? Can they physically handle it? Is there transportation? Is there someone to go with them?

What is the potential for side effects, and what happens if your parent experiences them? Make sure you understand this clearly. Ask the researchers what side effects have been seen in earlier studies. Ask what monitoring will be done to catch side effects early. Ask what happens if your parent has a serious side effect. Is there treatment for it? Does their participation end? Are they covered by insurance if something goes wrong?

What is the chance that your parent gets the real medication versus a placebo? If it's a randomized trial with a placebo group, understand that the odds might be 50/50, or they might be different depending on the trial design. If the trial is especially risky or if the placebo chance is high, think carefully about whether it makes sense for your parent.

What is the actual evidence that this medication or treatment might work? Ask the researchers. Ask your parent's regular doctor. Look at the evidence from earlier studies if you're able. Some trials are based on very early laboratory data. Others are based on promising results from earlier trials in humans. The stronger the evidence base, the more reasonable it is to hope for benefit.

What is your parent's condition right now? Trials for early Alzheimer's are different from trials for moderate to advanced Alzheimer's. Trials for people in the earliest stages of cognitive impairment might show benefit because there's time to slow progression. Trials for people with advanced dementia are less likely to show benefit because so much is already lost. Where your parent is in their disease trajectory matters.

What actually happens at the end of the trial? Will your parent get to continue the medication if it's working? Some trials offer this. Some don't. Some trials end and that's it, your parent goes back to not being on any disease-modifying treatment. Understanding what happens afterward matters.

What is your parent's own preference? This matters the most. Some people with cognitive decline are very interested in participating in research and want to contribute to science. Some are not interested. Some people want to try something new and feel like they're fighting the disease. Some people don't want to participate in research. Some people's preferences change as their cognitive decline progresses. Ideally, this decision should be made early, while your parent is cognitively intact enough to truly understand the trial and make the choice themselves.

How to Find Trials

If you want to look for clinical trials that your parent might be eligible for, there are a few resources.

ClinicalTrials.gov is a database maintained by the U.S. National Library of Medicine. It lists clinical trials that are recruiting participants. You can search by condition, by medication, by location. You can look at the trial information, the eligibility criteria, contact information for the research center. This is a good place to start.

Your parent's doctor might know about trials. Especially if they see a neurologist or a specialist in cognitive disorders, they might have relationships with researchers doing trials or know about trials happening locally.

Patient advocacy organizations often have information about trials. If your parent has been diagnosed with Alzheimer's, the Alzheimer's Association has information about trials. If it's a different condition, there might be a specific advocacy organization that has this information. These organizations also sometimes help match people to trials.

University medical centers often have clinical research going on. If there's a medical school near you, they might have memory disorders clinics or dementia research programs. You can call and ask.

Be careful about trials that approach you through marketing. Some trials heavily advertise for participants. This might be fine,it might just be how they're trying to recruit enough people to make the trial work. But be extra careful to evaluate whether the trial is legitimate and scientifically rigorous. Check who's running it. Is it a well-known academic medical center or a reputable research hospital? Is it run by researchers with genuine expertise in the field? Does the consent process seem thorough and honest?

The Decision Framework

Making this decision comes down to balancing hope with realism and respecting your parent's autonomy.

Hope matters. If your parent feels hopeful about a trial and wants to participate, that's meaningful. The belief that you're doing something, that you're fighting back against the disease, that you might get a medication before it's available to everyone,this can be psychologically valuable. It's not nothing. But hope needs to be grounded in reality. Your parent needs to understand what the realistic chances are.

Realism matters too. Your parent is not likely to get a cure. They're not likely to get a dramatic improvement. They might get modest slowing of decline. They might get nothing. They might get side effects. The participation will require time and effort. The burden is real. This needs to be considered alongside the hope.

Your parent's wishes matter most. If your parent is cognitively able, this is ultimately their decision. You can provide information. You can ask hard questions. But your parent should be the one who decides whether to participate. If your parent is no longer cognitively able to make this decision, then you need to think about what they would have wanted. Would they have wanted to participate in research if they were able to choose? What was their attitude toward medical research?

Some families decide that clinical trial participation makes sense. Their parent's condition is early enough that there's time for a medication to help. The time commitment is manageable. The side effect risk seems acceptable. The hope of contributing to science and maybe getting access to something new feels right. They do it.

Some families decide that clinical trial participation doesn't make sense. The burden of the trial protocol is too heavy. The realistic chances of benefit are too small. Their parent's condition is too advanced. They choose to focus on quality of life and currently available treatments instead.

Both decisions are reasonable. Both can be right for different families and different situations. What matters is making the decision carefully, with understanding of the real situation, and with your parent's preferences at the center.

How To Help Your Elders is an educational resource. We do not provide medical, legal, or financial advice. The information in this article is general in nature and may not apply to your specific situation. If you are concerned about a loved one's cognitive health or safety, consult with their healthcare provider or contact your local Area Agency on Aging for guidance and support.